BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17126006)

  • 1. Use of recombinant activated factor VII in massive obstetric haemorrhage.
    Haynes J; Laffan M; Plaat F
    Int J Obstet Anesth; 2007 Jan; 16(1):40-9. PubMed ID: 17126006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use].
    Courtois L; Becher P; Miot S; Maisonnette-Escot Y; Sautière JL; Berthier F; Samain E; Maillet R; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):78-82. PubMed ID: 17293258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
    Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
    Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience.
    Wissa I; Ebeid E; El-Shawarby S; Chandakas S; Kamal T; Hill N
    J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.
    Nicklin J; Perrin L; Crandon A; Land R; Nascimento M; Obermair A
    Aust N Z J Obstet Gynaecol; 2008 Aug; 48(4):447. PubMed ID: 18837857
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant factor VIIa for life-threatening post-partum haemorrhage.
    Ahonen J; Jokela R
    Br J Anaesth; 2005 May; 94(5):592-5. PubMed ID: 15708871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Manning BJ; Hynes N; Courtney DF; Sultan S
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.
    Heilmann L; Wild C; Hojnacki B; Pollow K
    Clin Appl Thromb Hemost; 2006 Apr; 12(2):227-9. PubMed ID: 16708127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
    Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U
    Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa should be used in massive obstetric haemorrhage.
    Van de Velde M
    Int J Obstet Anesth; 2007 Oct; 16(4):357-9. PubMed ID: 17702565
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant factor VIIa should be used in massive obstetric haemorrhage.
    Plaat F
    Int J Obstet Anesth; 2007 Oct; 16(4):354-7. PubMed ID: 17698342
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.
    Welsh A; McLintock C; Gatt S; Somerset D; Popham P; Ogle R
    Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):12-6. PubMed ID: 18275566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature.
    Shamsi TS; Hossain N; Soomro N; Hasan JA; Noorani M; Kazi S; Quraishy MS; Jameel B; Sultan ST; Haider S
    J Pak Med Assoc; 2005 Nov; 55(11):512-5. PubMed ID: 16304877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant activated factor VII as a life-saving therapy for severe postpartum haemorrhage unresponsive to conservative traditional management].
    Brice A; Hilbert U; Roger-Christoph S; Fernandez H; Dumenil AS; Descorps-Declère A; Mercier F; Benhamou D
    Ann Fr Anesth Reanim; 2004 Nov; 23(11):1084-8. PubMed ID: 15581725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of recombinant factor VIIa for the control of massive bleeding caused by uterine hypotonia in post-placental period].
    Tanchev S; Platikanov V; Markova S; Slavov N; Bogdanova A; Dimitrova D
    Akush Ginekol (Sofiia); 2004; 43(1):16-20. PubMed ID: 15168648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transfusion for post-partum haemorrhage: what's new in 2011?].
    Bonnet MP; Tesnière A; Mignon A
    Transfus Clin Biol; 2011 Apr; 18(2):129-32. PubMed ID: 21420343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of severe post-partum bleeding after caesarean section using recombinant activated factor VII].
    Holub Z; Feyereisl J; Kabelík L; Rittstein T
    Ceska Gynekol; 2005 Mar; 70(2):144, 146-8. PubMed ID: 15918270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
    Lim Y; Loo CC; Chia V; Fun W
    Int J Gynaecol Obstet; 2004 Nov; 87(2):178-9. PubMed ID: 15491576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of recombinant factor VIIa in massive post-partum haemorrhage.
    McMorrow RC; Ryan SM; Blunnie WP; Bowen M; Carton EG; Gardiner J; Geary M; Loughrey JP
    Eur J Anaesthesiol; 2008 Apr; 25(4):293-8. PubMed ID: 18177539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.